Search

Your search keyword '"Phenacetin chemistry"' showing total 68 results

Search Constraints

Start Over You searched for: Descriptor "Phenacetin chemistry" Remove constraint Descriptor: "Phenacetin chemistry"
68 results on '"Phenacetin chemistry"'

Search Results

1. Thermodynamic Characteristics of Phenacetin in Solid State and Saturated Solutions in Several Neat and Binary Solvents.

2. Theoretical investigation on the contribution of HO, SO 4 - and CO 3 - radicals to the degradation of phenacetin in water: Mechanisms, kinetics, and toxicity evaluation.

3. Calycosin Influences the Metabolism of Five Probe Drugs in Rats.

4. Construction of DOX/APC co-loaded BiOI@CuS NPs for safe and highly effective CT imaging and chemo-photothermal therapy of lung cancer.

5. The Effect of Promiscuous Aggregation on in Vitro Drug Metabolism Assays.

6. Multivariate approaches for the development of quality control in-situ fiber optics dissolution methods for fixed-dose combination tablets.

7. Kinetic stability of amorphous solid dispersions with high content of the drug: A fast scanning calorimetry investigation.

8. Identification and Quantification of Cocaine and Active Adulterants in Coca-Paste Seized Samples: Useful Scientific Support to Health Care.

9. Increased Phenacetin Oxidation upon the L382V Substitution in Cytochrome P450 1A2 is Associated with Altered Substrate Binding Orientation.

10. Microspherical Particles of Solid Dispersion of Polyvinylpyrrolidone K29-32 for Inhalation Administration.

11. In vivo pharmacokinetic interaction by ethanolic extract of Gymnema sylvestre with CYP2C9 (Tolbutamide), CYP3A4 (Amlodipine) and CYP1A2 (Phenacetin) in rats.

12. IRMS to study a common cocaine cutting agent: phenacetin.

13. Electro-catalytic oxidation of phenacetin with a three-dimensional reactor: Degradation pathway and removal mechanism.

14. Predicting the excess solubility of acetanilide, acetaminophen, phenacetin, benzocaine, and caffeine in binary water/ethanol mixtures via molecular simulation.

15. Multianalyte determination of the kinetic rate constants of drug-cyclodextrin supermolecules by high performance affinity chromatography.

16. Understanding the degradation of electrochemically-generated reactive drug metabolites by quantitative NMR.

17. In situ NMR spectroelectrochemistry for the structure elucidation of unstable intermediate metabolites.

18. Development of qualitative and quantitative analysis methods in pharmaceutical application with new selective signal excitation methods for 13 C solid-state nuclear magnetic resonance using 1 H T1rho relaxation time.

19. Preferred binding orientations of phenacetin in CYP1A1 and CYP1A2 are associated with isoform-selective metabolism.

20. Combined use of filtered and edited 1 H NMR spectroscopy to detect 13 C-enriched compounds in complex mixtures.

21. Application of incoherent inelastic neutron scattering in pharmaceutical analysis: relaxation dynamics in phenacetin.

22. Electron attachment to antipyretics: possible implications of their metabolic pathways.

23. Quantitation of pyrrole-imidazole polyamide in rat plasma by high-performance liquid chromatography coupled with UV detection.

24. Electrochemical oxidation by square-wave potential pulses in the imitation of phenacetin to acetaminophen biotransformation.

25. Bromination of selected pharmaceuticals in water matrices.

26. Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000.

27. Phenacetin and analgesic mixtures containing phenacetin.

28. Simultaneous quantification of capsaicin and dihydrocapsaicin in rat plasma using HPLC coupled with tandem mass spectrometry.

29. Small scale screening to determine the ability of different polymers to inhibit drug crystallization upon rapid solvent evaporation.

30. Kinetics of aqueous chlorination of some pharmaceuticals and their elimination from water matrices.

31. Phenacetin isolated from Bursera grandifolia, a herbal remedy with antipyretic properties.

32. Thermodynamics of cosolvent action: phenacetin, salicylic acid and probenecid.

33. Nuclear magnetic resonance spectroscopy as a quantitative tool to determine the concentrations of biologically produced metabolites: implications in metabolites in safety testing.

34. Key residues controlling phenacetin metabolism by human cytochrome P450 2A enzymes.

35. Use of prediction methods to estimate true density of active pharmaceutical ingredients.

36. Properties of pellets manufactured by wet extrusion/spheronization process using kappa-carrageenan: effect of process parameters.

37. Characterization of tableting using the OSDRC system.

38. Towards an understanding of the molecular mechanism of solvation of drug molecules: a thermodynamic approach by crystal lattice energy, sublimation, and solubility exemplified by paracetamol, acetanilide, and phenacetin.

39. Solubility parameter of drugs for predicting the solubility profile type within a wide polarity range in solvent mixtures.

40. [Effect of some non-steroidal antiinflammatory drugs and isomeric dihydroxy benzoic acids on the AAPH initiated degradation of crocin].

41. Spectroscopic investigation of the novel charge-transfer complex [(phen)(TCNE)(12)] formed in the reaction of phenacetin with tetracyanoethylene.

42. Thermodynamic study of the transfer of acetanilide and phenacetin from water to different organic solvents.

43. High-performance liquid chromatography/inductively coupled plasma mass spectrometry and tandem mass spectrometry for the detection of carbon-containing compounds.

44. Polymer particle erosion controlling drug release. I. Factors influencing drug release and characterization of the release mechanism.

45. Oxidations of p-alkoxyacylanilides catalyzed by human cytochrome P450 1A2: structure-activity relationships and simulation of rate constants of individual steps in catalysis.

46. Suppression of agglomeration in fluidized bed coating. IV. Effects of sodium citrate concentration on the suppression of particle agglomeration and the physical properties of HPMC film.

47. Analysis of the phase solubility diagram of a phenacetin/competitor/beta-cyclodextrin ternary system, involving competitive inclusion complexation.

48. Rate-determining steps in phenacetin oxidations by human cytochrome P450 1A2 and selected mutants.

49. Reduction of hydroxamic acids to the corresponding amides catalyzed by rabbit blood.

50. Controlled release from solid dispersion composed of poly(ethylene oxide)-Carbopol interpolymer complex with various cross-linking degrees of Carbopol.

Catalog

Books, media, physical & digital resources